Skip to main content

and
  1. Article

    Open Access

    Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

    The impact of genetic variability of pharmacogenes as a possible risk factor for adverse drug reactions is elucidated in the EMPAR (Einfluss metabolischer Profile auf die Arzneimitteltherapiesicherheit in der ...

    Jochen Fracowiak, Tatjana Huebner, Steffen Heß in The Pharmacogenomics Journal (2022)

  2. Article

    Open Access

    Improving the continuity and coordination of ambulatory care through feedback and facilitated dialogue—a study protocol for a cluster-randomised trial to evaluate the ACD study (Accountable Care in Germany)

    Patients in Germany are free to seek care from any office-based physician and can always ask for multiple opinions on a diagnosis or treatment. The high density of physicians and the freedom to choose among th...

    Leonie Sundmacher, Ronja Flemming, Verena Leve, Isabel Geiger, Sebastian Franke in Trials (2021)

  3. No Access

    Article

    New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

    The vast majority of the world population is infected with at least one member of the human herpesvirus family. Herpes simplex virus (HSV) infections are the cause of cold sores and genital herpes as well as l...

    Gerald Kleymann, Rüdiger Fischer, Ulrich A.K. Betz, Martin Hendrix in Nature Medicine (2002)